The CB1 cannabinoid receptor antagonist AM251 blocks amphetamine-induced behavioural sensitization together with monoamine changes in the mouse nucleus accumbens and hippocampus

G. Thiemann, V. Di Marzo, A. Molleman, R. Hasenoehrl

    Research output: Contribution to journalArticlepeer-review

    37 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The CB1 cannabinoid receptor antagonist AM251 blocks amphetamine-induced behavioural sensitization together with monoamine changes in the mouse nucleus accumbens and hippocampus'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemistry